migraine%20headache
MIGRAINE HEADACHE
Migraine headache without aura has at least 5 attacks of any 2 symptoms of unilateral headache that is throbbing or pulsating in nature, moderate to severe in pain and activity aggravates pain. It is accompanied with either nausea and vomiting or photophobia &/or phonophobia. The symptoms last for 4-72 hours without signs of secondary headache.
Migraine headache with aura has at least 2 attacks with any of the fully reversible symptoms of flickering lights, spots or lines &/or vision loss, sensory symptoms of pins & needles &/or numbness and dysphasic speech disturbance but without motor weakness. Accompanied by at least 2 of the following symptoms of homonymous visual symptoms &/or unilateral sensory symptoms or at least 1 aura symptoms develop gradually over ≥5 minutes &/or different aura symptoms that occur in succession over ≥5 minutes.
  1. Aukerman G, Knutson D, Miser WF. Management of the acute migraine headache. Am Fam Physician. 2002 Dec;66(11):2123-2130. http://www.aafp.org. PMID: 12484694
  2. Dowson AJ, Lipscombe S, Sender J, et al. New guidelines for the management of migraine in primary care. Curr Med Res Opin. 2002;18(7):414-439. PMID: 12487508
  3. Dodick DW. Acute and prophylactic management of migraine. Clin Cornerstone. 2001;4(3):36-52. PMID: 12739315
  4. Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force. Eur J Neurol. 2009 Sep;16(9):968-981. doi: 10.1111/j.1468-1331.2009.02748.x. PMID: 19708964
  5. Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Engl J Med. 2002 Jan;346(4):257-270. http://www.nejm.org. PMID: 11807151
  6. Ferrari MD. Migraine. Lancet. 1998 Apr;351(9108):1043-1051. PMID: 9546526
  7. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24(Suppl 1):9-160. PMID: 14979299
  8. Schoerder BM. AAFP/ACP-ASIM release guidelines on the management and prevention of migraines. Am Fam Physician. 2003 Mar;67(6):1391-1397. http://www.aafp.org. PMID: 12674472
  9. Morey SS. Guidelines on migraine: part 5. Recommendations for specific prophylactic drugs. Am Fam Physician. 2000 Dec;62(11):2535-2539. http://www.aafp.org. PMID: 11130237
  10. Nattero G, Agostoni A, Brandi G, et al. Therapeutic possibilities in idiopathic headaches. Analysis of about 1000 cases [abstract, in italian]. Minerva Med. 1976 Jun;67(31):1999-2006. PMID: 934545
  11. Martin V, Elkind A. Diagnosis and classification of primary headache disorders. Standards of Care for headache diagnosis and treatment. Chicago(IL): National Headache Foundation. 2004:004-18
  12. Siniachkin MS, Veĭn AM, Voznesenskaia TG, et al. Sulpride in the prophylactic treatment of migraine [abstract in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 1997;97(11):28-32. PMID: 9463033
  13. Silberstein SD, Holland S, Freitag F, et al. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012 Apr;78(17):1337-1345. http://www.ncbi.nlm.nih.gov. PMID: 22529202
  14. Silberstien SD for the US Headache Consortium. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000 Sep;55(6):754-762. PMID: 10993991
  15. Snow V, Weiss K, Wall EM, Mottur-Pilson C; American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med. 2002 Nov;137(10):840-849. http://annals.org. PMID: 12435222
  16. MedWormhttp://www.medworm.com/rss/index.php/Neurology/25/http://www.medworm.com/rss/medicalfeeds/specialities/Neurology.xml
  17. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  18. Scottish Intercollegiate Guidelines Network. Diagnosis and management of headache in adults. SIGN. http://www.sign.ac.uk. Nov 2008. Accessed 10 Feb 2011.
  19. Ministry of Health Singapore. Clinical practice guidelines: diagnosis and management of headache. MOH (Singapore). http://www.moh.gov.sg. 2007
  20. Institute for Clinical Systems Improvement (ICSI). Diagnosis and treatment of headache. http://www.icsi.org. Jan 2011. Accessed 10 Feb 2011.
  21. Ramadan NM, Silberstein SD, Freitag FG, et al. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraine. American Academy of Neurology. https://www.aan.com. Apr 2000.
  22. Campbell JK, Penzien DB, Wall EM. Evidence-based guidelines for migraine headache: behavioral and physical treatments. American Academy of Neurology. https://www.aan.com. 25 Apr 2000.
  23. Matchar DB, Young WB, Rosenberg JH, et al. Evidence-based guidelines for migraine headache in the primary care setting: Pharmacological management of acute attacks. American Academy of Neurology. https://www.aan.com. 2000.
  24. MacGregor EA, Steiner TJ, Davies PTG for the British Association for the Study of Headache. Guidelines for all healthcare professionals in the diagnosis & management of migraine, tension-type, cluster and medication-overuse headache. 3rd ed (1st rev). BASH. http://www.bash.org.uk. Sep 2010.
  25. MIPCA: Migraine in Primary Care Advisors. MIPCA guidelines for the management of migraine in primary care. 2nd ed. http://www.mipca.org.uk. Jan 2004.
  26. Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies. Headache. 2015;55(1):3-20. doi: 10.1111/head.12499. PMID: 25600718
  27. Pringsheim T, Davenport W, Mackie G, et al. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci. 2012 Mar;39(2)(Suppl 2):S1-S59. http://headachenetwork.ca. Accessed 14 Apr 2016. PMID: 22683887
  28. Bajwa ZH, Smith JH. Acute treatment of migraine in adults. UpToDate. https://www.uptodate.com. Mar 2019. Accessed 2 May 2017.
  29. Becker WJ. Acute migraine treatment in adults. Headache. 2015 Jun;55(6):778-793. doi: 10.1111/head.12550. Accessed 2 May 2017. PMID: 25877672
  30. Cutrer FM, Bajwa ZH. Pathophysiology, clinical manifestations, and diagnosis of migraine in adults. UpToDate. https://www.uptodate.com. Mar 2017.
  31. Garza I, Schwedt TJ. Chronic migraine. UpToDate. https://www.uptodate.com. Mar 2017.
  32. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013 Jul;33(9):629-808. doi: 10.1177/0333102413485658. Accessed 2 May 2017. PMID: 23771276
  33. Peng KP, Wang SJ. Epidemiology of headache disorders in the Asia-pacific region. Headache. 2014 Apr;54(4):610-618. doi: 10.1111/head.12328. PMID: 24666014
  34. Robertson CE, Black DF, Swanson JW. Management of migraine headache in the emergency department. Semin Neurol. 2010 Apr;30(2):201-211. doi: 10.1055/s-0030-1249228. PMID: 20352590
  35. Rozen TD. Emergency department and inpatient management of status migrainosus and intractable headache. Continuum (Minneap Minn). 2015 Aug;21(4):1004-1017. doi: 10.1212/CON.0000000000000191. PMID: 26252587
  36. World Health Organization. Headache disorders. WHO. http://www.who.int. Apr 2016. Accessed 24 Mar 2017.
  37. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalagia. 2018;38(1):1-211. doi: 10.1177/0333102417738202. Accessed 10 Aug 2018. PMID: 29368949
  38. American Headache Society. The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache. 2019 Jan;59(1):1-18. doi: 10.1111/head.13456. PMID: 30536394
  39. Bajwa ZH, Smith JH. Preventive treatment of migraine in adults. UpToDate. http://www.uptodate.com. Dec 2018.
  40. Diener HC, Holle-Lee D, Nägel S, et al. Treatment of migraine attacks and prevention of migraine: guidelines by the German Migraine and Headache Society and the German Society of Neurology. Clinical and Translational Neuroscience. 2019:1-40. doi: 10.1177/2514183X18823377.
  41. MacGregor A. Management of migraine during pregnancy. Progress in Neurology and Psychiatry banner. 2009 Oct;13(5):21-24. doi: 10.1002/pnp.137.
  42. National Institute for Health and Clinical Excellence. Botulinum toxin type A to prevent chronic migraine headaches. NICE. http://www.nice.org.uk. Jun 2012. Accessed 04 Jun 2019.
  43. Robbins MS. Migraine in pregnancy.. American Headache Society. http://www.americanheadachesociety.org.
Editor's Recommendations
Most Read Articles
4 days ago
Cardiac biomarkers are useful for identifying community-acquired pneumonia (CAP) patients with an elevated risk of early and long-term cardiovascular (CV) events, according to a study.
2 days ago
Tofogliflozin is safe and effective for elderly patients with type 2 diabetes mellitus (T2DM), regardless of insulin and oral antidiabetic drugs, reports a new Japan study.
17 Aug 2019
Pulmonary function has potential predictive value for future increases in arterial stiffness and its progression, as reported in a recent study.
5 days ago
Systolic blood pressure appears to have a strong association with aneurysmal subarachnoid haemorrhage (aSAH) but not with unruptured intracranial aneurysm (UIA), whereas current smoking and female sex are risk factors for both conditions, a study has found.